Apex Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$6.76M Buy
203,827
+34,812
+21% +$1.09M 0.15% 138
2015
Q4
$6.39M Buy
169,015
+11,859
+8% +$399K 0.14% 133
2015
Q3
$4.07M Buy
157,156
+11,022
+8% +$334K 0.09% 160
2015
Q2
$4.53M Sell
146,134
-442,458
-75% -$13M 0.1% 156
2015
Q1
$19.6M Buy
588,592
+66,218
+13% +$2.24M 0.46% 69
2014
Q4
$24.1M Buy
522,374
+460,875
+749% +$19.7M 0.64% 61
2014
Q3
$2.27M Buy
61,499
+27,651
+82% +$1.01M 0.07% 167
2014
Q2
$1.34M Buy
33,848
+4,603
+16% +$177K 0.04% 182
2014
Q1
$1.39M Buy
+29,245
New +$1.29M 0.05% 180

Other funds holding PODD

Apex Capital Management's PODD Position: Q1 2016 in Review

Apex Capital Management increased its Insulet (PODD) stake by 21% in Q1 2016, buying an estimated $1.09M and bringing the position to 203,827 shares worth $6.76M. The position accounts for 0.15% of the portfolio, ranked #138.

Apex Capital Management first reported a position in PODD in Q1 2014 and has held it in 9 quarters since. The position peaked at $24.1M in Q4 2014. 156 funds tracked by Wall St. Rank hold PODD as of Q1 2016.

  • Apex Capital Management held 203,827 shares of Insulet worth $6.76M as of Q1 2016.
  • Apex Capital Management bought 34,812 Insulet shares in Q1 2016, an estimated $1.09M.
  • Insulet made up 0.15% of Apex Capital Management's portfolio in Q1 2016, its #138 holding.
  • Apex Capital Management first reported a position in Insulet in Q1 2014 and has held it in 9 quarters since.
  • Apex Capital Management's Insulet position peaked at $24.1M in Q4 2014.
  • 156 funds tracked by Wall St. Rank held Insulet as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.